342 related articles for article (PubMed ID: 23523316)
1. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
Klaver YL; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
3. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
[TBL] [Abstract][Full Text] [Related]
4. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
[TBL] [Abstract][Full Text] [Related]
5. Incurable colorectal carcinoma: the role of surgical palliation.
Cummins ER; Vick KD; Poole GV
Am Surg; 2004 May; 70(5):433-7. PubMed ID: 15156952
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis.
Matsuda K; Hotta T; Takifuji K; Yamamoto M; Nasu T; Togo N; Oka M; Tabuse K; Yamaue H
Surgery; 2012 Feb; 151(2):238-44. PubMed ID: 21176934
[TBL] [Abstract][Full Text] [Related]
7. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
[TBL] [Abstract][Full Text] [Related]
9. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
[TBL] [Abstract][Full Text] [Related]
10. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
Maggiori L; Goéré D; Viana B; Tzanis D; Dumont F; Honoré C; Eveno C; Elias D
Ann Surg; 2013 Jul; 258(1):116-21. PubMed ID: 23207243
[TBL] [Abstract][Full Text] [Related]
11. Lymph nodes ratio is associated with the survival of colorectal cancer patients with peritoneal carcinomatosis.
Matsuda K; Hotta T; Takifuji K; Kobayashi Y; Tsuji T; Nagai Y; Horiuchi T; Yamaue H
Am Surg; 2011 May; 77(5):602-7. PubMed ID: 21679595
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal carcinomatosis in t4 colorectal cancer: occurrence and risk factors.
van Santvoort HC; Braam HJ; Spekreijse KR; Koning NR; de Bruin PC; de Vries Reilingh TS; Boerma D; Smits AB; Wiezer MJ; van Ramshorst B
Ann Surg Oncol; 2014 May; 21(5):1686-91. PubMed ID: 24398543
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
[TBL] [Abstract][Full Text] [Related]
14. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
Klaver YL; Chua TC; de Hingh IH; Morris DL
J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prognosis of synchronous colorectal carcinomatosis.
Goéré D; Allard MA; Honoré C; Dumont F; Elias D
Future Oncol; 2013 Apr; 9(4):541-9. PubMed ID: 23560376
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal carcinomatosis is less frequently diagnosed during laparoscopic surgery compared to open surgery in patients with colorectal cancer.
Thomassen I; van Gestel YRBM; Aalbers AGJ; van Oudheusden TR; Wegdam JA; Lemmens VEPP; de Hingh IHJT
Eur J Surg Oncol; 2014 May; 40(5):511-514. PubMed ID: 24534364
[TBL] [Abstract][Full Text] [Related]
19. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases.
Mulsow J; Merkel S; Agaimy A; Hohenberger W
Br J Surg; 2011 Dec; 98(12):1785-91. PubMed ID: 22034185
[TBL] [Abstract][Full Text] [Related]
20. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin.
Klaver YL; Leenders BJ; Creemers GJ; Rutten HJ; Verwaal VJ; Lemmens VE; de Hingh IH
Am J Clin Oncol; 2013 Apr; 36(2):157-61. PubMed ID: 22314003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]